4 completed, 1 withdrawn. 3 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 3 |
Follow Alzheimer Disease 10: new trials by email Literature Review of Alzheimer Disease 10 trials Research Report on Alzheimer Disease 10
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cognitive Stimulation Therapy Cognitive Stimulation Therapy - Alzheimer Disease 10, Dementia | Not applicable | Completed | Hasan Kalyoncu University | 56 | 2023-05-01 | 2024-03-15 |
| A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study) Spectris™ AD - Active, Spectris™ AD - Sham - Alzheimer Disease, Alzheimer Disease 1 | Not applicable | Completed | Cognito Therapeutics, Inc. | 673 | 2022-12-13 | 2026-09-09 |
| A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Alzheimer's Disease No Intervention - Alzheimer Disease, Alzheimer Disease 1 | Withdrawn | ProgenaBiome | 2020-03-02 | 2025-06-05 | ||
| Exercise and the Receptor for Advanced Glycation End Products (RAGE) Aerobic Exercise - Diabetes Mellitus, Type 2 | Not applicable | Completed | University of Michigan | 50 | 2018-12-20 | 2024-08-13 |
| Disulfiram as a Modulator of Amyloid Precursor Protein-processing Disulfiram - Alcohol Addiction | Completed | Johannes Gutenberg University Mainz | 17 | 2013-05-01 | 2017-07-24 |
Alzheimer Disease (4) · Alzheimer Disease 11 (2) · Alzheimer Disease 12 (2) · Alzheimer Disease 13 (2) · Alzheimer Disease 14 (2) · Alzheimer Disease 15 (2) · Alzheimer Disease 16 (2) · Alzheimer Disease 5 (2) · Alzheimer Disease 6 (2) · Alzheimer Disease 7 (2) · Alzheimer Disease 8 (2) · Alzheimer Disease 9 (2) · Alzheimer disease type 1 (2) · Alzheimer disease type 2 (2)
Brain Diseases (4) · Central Nervous System Diseases (4) · Mental Disorders (4) · Nervous System Diseases (4) · Neurocognitive Disorders (4) · Neurodegenerative Diseases (4) · Tauopathies (4) · Dementia (2) · Alcohol-Related Disorders (1) · Behavior (1) · Chemically-Induced Disorders (1) · Cognition Disorders (1) · Diabetes Mellitus (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1)
Disulfiram (1) · Exercise (1)
Cognito Therapeutics, Inc. (1) · Hasan Kalyoncu University (1) · Johannes Gutenberg University Mainz (1) · ProgenaBiome (1) · University of Michigan (1)
United States (3) · Turkey (Türkiye) (1)
Jacob Haus, PhD (1) · Kristina Endres (1) · Robbert Zusterzeel, MD, PhD, MPH (1) · Sabine Hazan, MD (1)
R01DK109948 (1)